Condition

Non-hodgkin Lymphoma,B Cell clinical trials and research

• 10Clinical trials
• 4Countries

Newest Non-hodgkin Lymphoma,B Cell clinical trials

All recruiting trials (10)

• Universal CAR-T therapy for CD19-positive B‑cell non-Hodgkin lymphoma

  This study will try an off‑the‑shelf CAR‑T product called BRL‑301 in adults with CD19‑positive B‑cell non‑Hodgkin lymphoma to see if a single 5×10^6/kg dose is safe and shows anti‑tumor activity.

  Recruiting Bioray Laboratories · Shanghai · NCT07248163

• Allogeneic CD19-targeting CAR-γδT cell therapy (QH103E) for relapsed or refractory B‑cell non-Hodgkin lymphoma.

  This will try an off-the-shelf, gene-edited CD19-directed CAR-γδT cell infusion (QH103E) in adults with relapsed or refractory B‑cell non-Hodgkin lymphoma.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06838832

• Treatment of relapsed B-cell Non-Hodgkin lymphoma with CAR-T cells

  This study is testing a new type of CAR-T cell treatment to see if it can help people with relapsed B-cell Non-Hodgkin lymphoma feel better and achieve remission.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06716164

• Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310

  This study is testing a new treatment called SynKIR-310 to see if it can help adults with relapsed or refractory B-cell lymphoma feel better.

  Recruiting at 5 sites Phase 1 Verismo Therapeutics · Denver, Colorado and 4 other locations · NCT06544265

• CD19-BAFF CAR-T cell therapy for relapsed B-cell leukemia and lymphoma

  This study is testing a new CAR-T cell therapy for people with relapsed B-cell leukemia and lymphoma to see if it is safe and effective.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06346912

• New T Cell Therapy for Relapsed B-Cell Non-Hodgkin Lymphoma

  This study is testing a new T cell therapy for people with relapsed B-cell non-Hodgkin lymphoma to see if it can help fight their cancer while reducing side effects.

  Recruiting at 2 sites Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06321289

• Evaluating sarcopenia in lymphoma patients receiving CAR-T therapy

  This study is trying to see if measuring muscle loss and overall health can help predict how well CAR-T therapy works and what side effects it might cause in adults with B-cell non-Hodgkin lymphoma.

  Recruiting at 20 sites Fondazione Italiana Linfomi - ETS · Alessandria and 20 other locations · NCT06156774

• CAR T-cell therapy for patients with kidney issues

  This study is testing if CAR T-cell therapy can be safely given to patients with kidney problems who are getting chemotherapy for blood cancers like multiple myeloma, leukemia, or lymphoma.

  Recruiting Phase 2 Northside Hospital, Inc. · Atlanta, Georgia · NCT05909059

• Evaluating BRL-201 for treating relapsed/refractory B-cell Non-Hodgkin Lymphoma

  This study is testing a new CAR-T cell therapy called BRL-201 to see if it can help people with relapsed or hard-to-treat B-cell Non-Hodgkin Lymphoma.

  Recruiting at 3 sites Phase 1 Bioray Laboratories · Wuhan, Hubei and 2 other locations · NCT05741359

• Treatment protocol for B-cell mature non-Hodgkin's lymphoma in children and adolescents

  This study is testing different treatment plans for children and teenagers with B-cell non-Hodgkin's lymphoma to see who needs stronger therapy and who can safely have gentler options.

  Recruiting Phase 4 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow, RF · NCT05518383

Related topics

Quick answers

How many Non-hodgkin Lymphoma,B Cell clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (6 trials), United States (2 trials), Italy (1 trial), Russia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 1/2: 2, Early Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →